United States Biotechnology & Medical Research

Immix Biopharma Inc (IMMX)

Track

Track

Immix Biopharma Inc. insiders have exclusively engaged in purchase activity over the observed period. The most recent transactions occurred on December 10, 2025, involving the CEO and CFO. These acquisitions follow a consistent pattern of accumulation by leadership throughout the year, reflecting ongoing participation from key executives in the company's equity.
Ticker: IMMX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Immix Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Morris Gabriel S CFO Executive Director
Transaction date
Purchase
Price
341.83
Quantity 8,883 -1.1%
Value US$872,679
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
311.49
Quantity 26,553 -18.0%
Value US$461,095
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
139.93
Quantity 52,719 -19.2%
Value US$2,262,471
3.8
Morris Gabriel S CFO Executive Director
Transaction date
Purchase
Price
1.97
Quantity 2,600 +0.9%
Value US$5,122
3.8
Morris Gabriel S CFO Executive Director
Transaction date
Purchase
Price
2.28
Quantity 2,225 +0.8%
Value US$5,071
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
2.30
Quantity 2,178 +0.2%
Value US$4,999
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.19
Quantity 40,000 +4.7%
Value US$87,680
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.17
Quantity 7,700 +0.9%
Value US$16,678
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.25
Quantity 8,100 +1.0%
Value US$18,233
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.23
Quantity 15,000 +1.8%
Value US$33,390
3.4
Ng Carey Non-Executive Director
Transaction date
Purchase
Price
1.86
Quantity 10,000 +100.0%
Value US$18,600
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.15
Quantity 6,000 +0.7%
Value US$12,877
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.07
Quantity 3,200 +0.4%
Value US$6,639
3.8
Morris Gabriel S CFO Executive Director
Transaction date
Purchase
Price
2.12
Quantity 2,500 +0.9%
Value US$5,298
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
2.13
Quantity 2,600 +0.2%
Value US$5,538
3.8
Morris Gabriel S CFO Executive Director
Transaction date
Purchase
Price
1.81
Quantity 3,300 +1.2%
Value US$5,973
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
1.81
Quantity 3,300 +0.3%
Value US$5,970
3.8
Morris Gabriel S CFO Executive Director
Transaction date
Purchase
Price
2.23
Quantity 4,500 +5.5%
Value US$10,042
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
2.25
Quantity 4,300 +0.5%
Value US$9,660
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
4.67
Quantity 31,000 +4.0%
Value US$144,894
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
4.88
Quantity 25,000 +3.3%
Value US$122,025
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.49
Quantity 7,000 +0.9%
Value US$17,396
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.58
Quantity 10,000 +1.4%
Value US$25,772
3.4
Ng Carey Non-Executive Director
Transaction date
Purchase
Price
2.58
Quantity 10,000 +inf%
Value US$25,760
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.83
Quantity 30,000 +4.2%
Value US$84,864
3.3
Adams Helen C. Non-Executive Director
Transaction date
Purchase
Price
2.96
Quantity 13,000 +inf%
Value US$38,492
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.89
Quantity 25,000 +3.6%
Value US$72,280
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
2.53
Quantity 10,000 +1.5%
Value US$25,317
3.2
BUCHAN MELISSA JANE Non-Executive Director
Transaction date
Purchase
Price
2.46
Quantity 20,000 +inf%
Value US$49,226
1.9
Marquet Magda Non-Executive Director
Transaction date
Purchase
Price
2.47
Quantity 9,000 +81.8%
Value US$22,213
1.9
Marquet Magda Non-Executive Director
Transaction date
Purchase
Price
2.47
Quantity 10,000 +1000.0%
Value US$24,722
1.9
Marquet Magda Non-Executive Director
Transaction date
Purchase
Price
2.01
Quantity 1,000 +inf%
Value US$2,010
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
0.99
Quantity 150 +0.0%
Value US$148
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
0.95
Quantity 1,000 +0.1%
Value US$950
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
1.02
Quantity 4,050 +0.4%
Value US$4,127
3.8
Morris Gabriel S CFO Executive Director
Transaction date
Purchase
Price
0.94
Quantity 5,200 +6.8%
Value US$4,888
3.3
Senn Sean Large shareholder
Transaction date
Sale
Price
2.75
Quantity 200 -0.0%
Value US$550
3.4
Ng Carey Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 25,000 +2.5%
Value US$125,000
3.8
Morris Gabriel S Chief Financial Officer Executive Director
Transaction date
Purchase
Price
5.00
Quantity 2,000 +2.7%
Value US$10,000
3.8
Rachman Ilya M CEO and Chairman Executive Director
Transaction date
Purchase
Price
5.00
Quantity 2,500 +0.3%
Value US$12,500
3.5
Hsu Jason Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 50,000 +inf%
Value US$250,000
1.4
Torchilin Vladimir P Scientific Co-Founder Officer
Transaction date
Purchase
Price
5.00
Quantity 3,000 +0.3%
Value US$15,000
1.4
Torchilin Vladimir P Scientific Co-Founder Officer
Transaction date
Purchase
Price
4.47
Quantity 2,200 +0.2%
Value US$9,834
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-10 2025-12-10 B Purchase
3.8
Morris Gabriel S

CFO

Executive Director
8,883 -1.1%
341.83
US$872,679 		8,883 -1.1% 341.83 US$872,679
2025-12-10 2025-12-10 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
26,553 -18.0%
311.49
US$461,095 		26,553 -18.0% 311.49 US$461,095
2025-09-17 2025-09-17 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
52,719 -19.2%
139.93
US$2,262,471 		52,719 -19.2% 139.93 US$2,262,471
2025-09-17 2025-09-16 B Purchase
3.8
Morris Gabriel S

CFO

Executive Director
2,600 +0.9%
1.97
US$5,122 		2,600 +0.9% 1.97 US$5,122
2025-06-20 2025-06-18 B Purchase
3.8
Morris Gabriel S

CFO

Executive Director
2,225 +0.8%
2.28
US$5,071 		2,225 +0.8% 2.28 US$5,071
2025-06-20 2025-06-18 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
2,178 +0.2%
2.30
US$4,999 		2,178 +0.2% 2.30 US$4,999
2024-12-26 2024-12-23 B Purchase
3.5
Hsu Jason
Non-Executive Director
40,000 +4.7%
2.19
US$87,680 		40,000 +4.7% 2.19 US$87,680
2024-12-26 2024-12-20 B Purchase
3.5
Hsu Jason
Non-Executive Director
7,700 +0.9%
2.17
US$16,678 		7,700 +0.9% 2.17 US$16,678
2024-08-26 2024-08-22 B Purchase
3.5
Hsu Jason
Non-Executive Director
8,100 +1.0%
2.25
US$18,233 		8,100 +1.0% 2.25 US$18,233
2024-08-26 2024-08-21 B Purchase
3.5
Hsu Jason
Non-Executive Director
15,000 +1.8%
2.23
US$33,390 		15,000 +1.8% 2.23 US$33,390
2024-08-19 2024-08-16 B Purchase
3.4
Ng Carey
Non-Executive Director
10,000 +100.0%
1.86
US$18,600 		10,000 +100.0% 1.86 US$18,600
2024-07-31 2024-07-24 B Purchase
3.5
Hsu Jason
Non-Executive Director
6,000 +0.7%
2.15
US$12,877 		6,000 +0.7% 2.15 US$12,877
2024-07-31 2024-07-18 B Purchase
3.5
Hsu Jason
Non-Executive Director
3,200 +0.4%
2.07
US$6,639 		3,200 +0.4% 2.07 US$6,639
2024-06-10 2024-06-07 B Purchase
3.8
Morris Gabriel S

CFO

Executive Director
2,500 +0.9%
2.12
US$5,298 		2,500 +0.9% 2.12 US$5,298
2024-06-10 2024-06-07 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
2,600 +0.2%
2.13
US$5,538 		2,600 +0.2% 2.13 US$5,538
2024-06-05 2024-06-04 B Purchase
3.8
Morris Gabriel S

CFO

Executive Director
3,300 +1.2%
1.81
US$5,973 		3,300 +1.2% 1.81 US$5,973
2024-06-05 2024-06-04 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
3,300 +0.3%
1.81
US$5,970 		3,300 +0.3% 1.81 US$5,970
2024-05-14 2024-05-14 B Purchase
3.8
Morris Gabriel S

CFO

Executive Director
4,500 +5.5%
2.23
US$10,042 		4,500 +5.5% 2.23 US$10,042
2024-05-14 2024-05-14 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
4,300 +0.5%
2.25
US$9,660 		4,300 +0.5% 2.25 US$9,660
2023-12-12 2023-12-11 B Purchase
3.5
Hsu Jason
Non-Executive Director
31,000 +4.0%
4.67
US$144,894 		31,000 +4.0% 4.67 US$144,894
2023-12-12 2023-12-08 B Purchase
3.5
Hsu Jason
Non-Executive Director
25,000 +3.3%
4.88
US$122,025 		25,000 +3.3% 4.88 US$122,025
2023-09-18 2023-09-15 B Purchase
3.5
Hsu Jason
Non-Executive Director
7,000 +0.9%
2.49
US$17,396 		7,000 +0.9% 2.49 US$17,396
2023-09-18 2023-09-14 B Purchase
3.5
Hsu Jason
Non-Executive Director
10,000 +1.4%
2.58
US$25,772 		10,000 +1.4% 2.58 US$25,772
2023-09-15 2023-09-14 B Purchase
3.4
Ng Carey
Non-Executive Director
10,000 +inf%
2.58
US$25,760 		10,000 +inf% 2.58 US$25,760
2023-09-18 2023-09-12 B Purchase
3.5
Hsu Jason
Non-Executive Director
30,000 +4.2%
2.83
US$84,864 		30,000 +4.2% 2.83 US$84,864
2023-09-14 2023-09-12 B Purchase
3.3
Adams Helen C.
Non-Executive Director
13,000 +inf%
2.96
US$38,492 		13,000 +inf% 2.96 US$38,492
2023-09-18 2023-09-11 B Purchase
3.5
Hsu Jason
Non-Executive Director
25,000 +3.6%
2.89
US$72,280 		25,000 +3.6% 2.89 US$72,280
2023-09-12 2023-09-08 B Purchase
3.5
Hsu Jason
Non-Executive Director
10,000 +1.5%
2.53
US$25,317 		10,000 +1.5% 2.53 US$25,317
2023-09-11 2023-09-07 B Purchase
3.2
BUCHAN MELISSA JANE
Non-Executive Director
20,000 +inf%
2.46
US$49,226 		20,000 +inf% 2.46 US$49,226
2023-09-08 2023-09-06 B Purchase
1.9
Marquet Magda
Non-Executive Director
9,000 +81.8%
2.47
US$22,213 		9,000 +81.8% 2.47 US$22,213
2023-09-06 2023-09-05 B Purchase
1.9
Marquet Magda
Non-Executive Director
10,000 +1000.0%
2.47
US$24,722 		10,000 +1000.0% 2.47 US$24,722
2023-09-05 2023-08-31 B Purchase
1.9
Marquet Magda
Non-Executive Director
1,000 +inf%
2.01
US$2,010 		1,000 +inf% 2.01 US$2,010
2022-11-15 2022-11-14 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
150 +0.0%
0.99
US$148 		150 +0.0% 0.99 US$148
2022-11-15 2022-11-14 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
1,000 +0.1%
0.95
US$950 		1,000 +0.1% 0.95 US$950
2022-11-15 2022-11-14 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
4,050 +0.4%
1.02
US$4,127 		4,050 +0.4% 1.02 US$4,127
2022-11-15 2022-11-14 B Purchase
3.8
Morris Gabriel S

CFO

Executive Director
5,200 +6.8%
0.94
US$4,888 		5,200 +6.8% 0.94 US$4,888
2022-07-18 2022-07-14 S Sale
3.3
Senn Sean
Large shareholder
200 -0.0%
2.75
US$550 		200 -0.0% 2.75 US$550
2021-12-20 2021-12-20 B Purchase
3.4
Ng Carey
Non-Executive Director
25,000 +2.5%
5.00
US$125,000 		25,000 +2.5% 5.00 US$125,000
2021-12-20 2021-12-20 B Purchase
3.8
Morris Gabriel S

Chief Financial Officer

Executive Director
2,000 +2.7%
5.00
US$10,000 		2,000 +2.7% 5.00 US$10,000
2021-12-20 2021-12-20 B Purchase
3.8
Rachman Ilya M

CEO and Chairman

Executive Director
2,500 +0.3%
5.00
US$12,500 		2,500 +0.3% 5.00 US$12,500
2021-12-20 2021-12-20 B Purchase
3.5
Hsu Jason
Non-Executive Director
50,000 +inf%
5.00
US$250,000 		50,000 +inf% 5.00 US$250,000
2021-12-20 2021-12-20 B Purchase
1.4
Torchilin Vladimir P

Scientific Co-Founder

Officer
3,000 +0.3%
5.00
US$15,000 		3,000 +0.3% 5.00 US$15,000
2021-12-20 2021-12-17 B Purchase
1.4
Torchilin Vladimir P

Scientific Co-Founder

Officer
2,200 +0.2%
4.47
US$9,834 		2,200 +0.2% 4.47 US$9,834
Explore more

More insider trading research around Immix Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America